Low-Frequency Ultrasound-Mediated Cytokine Transfection Enhances T Cell Recruitment at Local and Distant Tumor Sites
Low-frequency ultrasound-mediated cytokine transfection enhances T cell recruitment at local and distant tumor sites Tali Ilovitsha,b,c, Yi Fenga,b,d, Josquin Foireta,b, Azadeh Kheirolomooma,b,c, Hua Zhanga,b,c, Elizabeth S. Inghamc, Asaf Ilovitsha,b,c, Spencer K. Tumbalea,b, Brett Z. Fitea,b,BoWua,b, Marina N. Raiea,b, Nisi Zhanga,b, Aris J. Karea,b,e, Michael Chaveze, Lei S. Qie, Gadi Pelledf,g, Dan Gazitf,g, Ophir Vermesha,b, Idan Steinberga,b, Sanjiv S. Gambhira,b, and Katherine W. Ferraraa,b,1 aMolecular Imaging Program at Stanford, Stanford University, Stanford, CA 94305; bDepartment of Radiology, Stanford University, Stanford, CA 94305; cDepartment of Biomedical Engineering, University of California, Davis, CA 95616; dDepartment of Biomedical Engineering, Xi’an Jiaotong University, Xi’an 710049, People’s Republic of China; eDepartment of Bioengineering, Stanford University, Stanford, CA 94305; fDepartment of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048; and gBoard of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048 Edited by Rakesh K. Jain, Massachusetts General Hospital, Boston, MA, and approved April 3, 2020 (received for review August 28, 2019) Robust cytotoxic T cell infiltration has proven to be difficult to expression patterns, or replace a malfunctioning gene (7). Gene achieve in solid tumors. We set out to develop a flexible protocol therapy is now enhancing survival (8), and over 2,600 gene to efficiently transfect tumor and stromal cells to produce immune- therapy clinical trials have been completed, are ongoing, or have activating cytokines, and thus enhance T cell infiltration while been approved worldwide (9).
[Show full text]